BCL2L2 antibody
Quick Overview for BCL2L2 antibody (ABIN6936493)
Target
See all BCL2L2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Specificity
- BCLW promotes cell survival. Blocks dexamethasone-induced apoptosis. Mediates survival of postmitotic Sertoli cells by suppressing death-promoting activity of BAX.
-
Cross-Reactivity (Details)
- Human.
-
Purification
- 1.0mg/ml of Ab purified from Bioreactor by Protein A/G.
-
Immunogen
- Recombinant human full-length BCL2L2 protein
-
Isotype
- IgG1 kappa
-
-
-
-
Application Notes
-
Known_Application: ELISA (For coating, order antibody without BSA), ,Western Blot (1-2 μg/mL), ,Optimal dilution for a specific application should be determined.
Positive_Control: PC-3, HEK293, HePG2, MCF-7 or U87 cells.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- Prepared in 10 mM PBS, WITHOUT BSA and Azide.
-
Preservative
- Azide free
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.
-
Expiry Date
- 24 months
-
-
- BCL2L2 (BCL2-Like 2 (BCL2L2))
-
Alternative Name
- BCL2L2
-
Background
-
BCL-W, BCL2-L-2, BCLW, KIAA0271, PPP1R51,BCL2-like 2
Cellular localisation: Ubiquitous cytoplasmic expression. -
Molecular Weight
- 22-30kDa
-
Gene ID
- 599, 410026
-
UniProt
- Q92843
Target
-